IP Library Granted Patent US 9,345,426
Granted Patent B2
US 9,345,426 · App. 13/853,095 · Granted May 24, 2016

Purification of glucose concentration signal in an implantable fluorescence based glucose sensor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,345,426
App. No.
13/853,095
Granted
May 24, 2016
Kind
B2
Abstract

Methods, sensors, and systems for determining a concentration of glucose in a medium of a living animal are disclosed. Determining the glucose concentration may involve emitting excitation light from a light source to indicator molecules, generating a raw signal indicative of the amount of light received by a photodetector, purifying and normalizing the raw signal, and converting the normalized signal to a glucose concentration. The purification may involve removing noise (e.g., offset and/or distortion) from the raw signal. The purification and normalization may involve tracking the cumulative emission time that the light source has emitted the excitation light and tracking the implant time that has elapsed since the optical sensor was implanted. The purification and normalization may involve measuring the temperature of the sensor. The purification, normalization, and conversion may involve using parameters determined during manufacturing, in vitro testing, and/or in vivo testing.

Claims (58)

1. A method of determining a concentration of glucose in a medium of a living animal using an optical sensor implanted in the living animal, the method comprising:

emitting, using a light source of the optical sensor, excitation light to indicator molecules of the optical sensor, the indicator molecules having an optical characteristic responsive to the concentration of glucose;

generating, using a photodetector of the optical sensor, a raw signal indicative of the amount of light received by the photodetector, wherein the light received by the photodetector includes glucose-modulated light emitted by the indicator molecules and at least one of excitation light emitted by the light source and non-glucose modulated light emitted by the indicator molecules;

tracking, using circuitry of the optical sensor, the cumulative emission time that the light source has emitted the excitation light;

tracking, using circuitry of the optical sensor, the implant time that has elapsed since the optical sensor was implanted in the living animal;

adjusting, using circuitry of the optical sensor, the raw signal to compensate for offset and distortion based on the tracked cumulative emission time and the tracked implant time;

converting, using circuitry of the optical sensor, the adjusted signal into a measurement of glucose concentration in the medium of the living animal; and

conveying, using an inductive element of the optical sensor, the measurement of glucose concentration.

2. The method of claim 1 , further comprising:

measuring, using a temperature sensor of the optical sensor, a temperature of the optical sensor;

correcting, using circuitry of the optical sensor, the raw signal to compensate for temperature sensitivity of the light source based on the measured temperature.

3. The method of claim 1 , wherein the non-glucose modulated light emitted by the indicator molecules comprises light emitted by distortion producing indicator molecule subspecies.

4. The method of claim 3 , wherein the distortion producing indicator molecule subspecies include oxidated species, and adjusting the raw signal comprises:

calculating the light emitted by the oxidated species based on the tracked cumulative emission time and the tracked implant time; and

subtracting the calculated light emitted by the oxidated species from the raw signal.

5. The method of claim 4 , wherein the distortion producing indicator molecule subspecies include photo-activated oxidated species, and adjusting the raw signal comprises:

calculating the light emitted by the photo-activated oxidated species based on the tracked cumulative emission time and the tracked implant time; and

subtracting the calculated light emitted by the photo-activated oxidated species from the raw signal.

6. The method of claim 3 , wherein the distortion producing indicator molecule subspecies include thermal degradation product species, and adjusting the raw signal comprises:

calculating the light emitted by the thermal degradation product species based on the tracked cumulative emission time and the tracked implant time; and

subtracting the calculated light emitted by the thermal degradation product species from the raw signal.

7. The method of claim 1 , wherein the offset is hardware based, and adjusting the raw signal comprises:

calculating the offset based on the tracked cumulative emission time; and

subtracting the calculated offset from the raw signal.

8. The method of claim 1 , wherein the adjusted signal is directly proportional to glucose concentration in the medium.

9. The method of claim 1 , wherein the glucose-modulated light is emitted by active indicator species of the indicator molecules.

10. The method of claim 9 , wherein adjusting the raw signal comprises normalizing the raw signal to a normalized raw signal that would be equal to one at zero glucose concentration.

11. The method of claim 10 , wherein normalizing comprises:

calculating the amount of light emitted by the active indicator species at zero glucose concentration based on the tracked cumulative emission time and the tracked implant time; and

dividing the raw signal by the calculated amount of light emitted by the active indicator species at zero glucose concentration.

12. The method of claim 10 , further comprising measuring, using a temperature sensor of the optical sensor, a temperature of the optical sensor;

wherein calculating the amount of light emitted by the active indicator species at zero glucose concentration is based on the measured temperature, the tracked cumulative emission time, and the tracked implant time.

13. The method of claim 1 , wherein the non-glucose modulated light is emitted by oxidated species, photo-activated oxidated species, and/or photo-activated oxidated species of the indicator molecules.

14. An optical sensor for determining a concentration of glucose in a medium of a living animal, the sensor comprising:

indicator molecules having an optical characteristic responsive to the concentration of glucose;

a light source configured to emit excitation light to the indicator molecules;

a photodetector configured to generate a raw signal indicative of the amount of light received by the photodetector, wherein the light received by the photodetector includes glucose-modulated light emitted by the indicator molecules and at least one of excitation light emitted by the light source and non-glucose modulated light emitted by the indicator molecules;

circuitry configured to:

track the cumulative emission time that the light source has emitted the excitation light;

track the implant time that has elapsed since the optical sensor was implanted in the living animal;

adjust the raw signal to compensate for offset and distortion based on the tracked cumulative emission time and the tracked implant time; and

convert the adjusted signal into a measurement of glucose concentration in the medium of the living animal; and

an inductive element configured to convey the measurement of glucose concentration.

15. The optical sensor of claim 14 , further comprising a temperature sensor configured to measure a temperature of the optical sensor;

wherein the circuitry is further configured to correct the raw signal to compensate for temperature sensitivity of the light source based on the measured temperature.

16. The optical sensor of claim 14 , wherein the circuitry is further configured to normalize the raw signal to a normalized raw signal that would be equal to one at zero glucose concentration.

17. A method of determining a concentration of glucose in a medium of a living animal using an optical sensor implanted in the living animal, the method comprising:

emitting, using a light source of the optical sensor, excitation light to indicator molecules of the optical sensor, the indicator molecules having an optical characteristic responsive to the concentration of glucose;

generating, using a photodetector of the optical sensor, a raw signal indicative of the amount of light received by the photodetector, wherein the light received by the photodetector includes glucose-modulated light emitted by the indicator molecules and at least one of excitation light emitted by the light source and non-glucose modulated light emitted by the indicator molecules;

measuring, using a temperature sensor of the optical sensor, a temperature of the optical sensor;

tracking the cumulative emission time that the light source has emitted the excitation light;

tracking the implant time that has elapsed since the optical sensor was implanted in the living animal;

temperature correcting, using circuitry of the optical sensor, the raw signal to compensate for temperature sensitivity of the light source based on the measured temperature;

offset adjusting, using the circuitry of the optical sensor, the temperature corrected raw signal to compensate for offset based on the tracked cumulative emission time;

distortion adjusting, using the circuitry of the optical sensor, the offset adjusted raw signal to compensate for distortion based on the tracked cumulative emission time and the tracked implant time;

normalizing, using the circuitry of the optical sensor, the distortion adjusted raw signal to a normalized raw signal that would be equal to one at zero glucose concentration based on the measured temperature, the tracked cumulative emission time, and the tracked implant time;

converting, using the circuitry of the optical sensor, the normalized raw signal into a measurement of glucose concentration in the medium of the living animal; and

conveying, using an inductive element of the optical sensor, the measurement of glucose concentration.

Assignments (12)
SECURITY INTEREST Recorded Sep 11, 2023
From: SENSEONICS, INCORPORATED
To: HERCULES CAPITAL, INC.
Reel/Frame 064866/0963 →
RELEASE OF SECURITY INTEREST Recorded Sep 7, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 064834/0962 →
RELEASE OF SECURITY INTEREST Recorded Apr 14, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: SENSEONICS HOLDINGS, INC.; SENSEONICS, INCORPORATED
Reel/Frame 063338/0890 →
RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Aug 14, 2020
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 053498/0275 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 14, 2020
From: SENSEONICS, INCORPORATED
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 053496/0292 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - FIRST LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052492/0109 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT -SECOND LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052490/0160 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2020
From: SOLAR CAPITAL LTD., AS AGENT
To: SENSEONICS, INCORPORATED
Reel/Frame 052207/0242 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 1, 2019
From: SENSEONICS, INCORPORATED
To: SOLAR CAPITAL LTD., AS AGENT
Reel/Frame 049926/0827 →
RELEASE OF SECURITY INTEREST Recorded Jul 25, 2019
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER
To: SENSEONICS, INCORPORATED
Reel/Frame 049873/0713 →
SECURITY INTEREST Recorded Jan 26, 2018
From: SENSEONICS, INCORPORATED
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER
Reel/Frame 045164/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2014
From: COLVIN, ARTHUR E., JR; WANG, XIAOLIN; MDINGI, COLLEEN; DEHENNIS, ANDREW
To: SENSEONICS, INCORPORATED
Reel/Frame 033650/0453 →